Qual é o preço para Celyad Oncology S.A. (CYAD)

O preço para Celyad Oncology S.A. (CYAD) é $0.33686807

Qual é a capitalização de mercado para Celyad Oncology S.A. (CYAD)

A capitalização de mercado para Celyad Oncology S.A. (CYAD) é $15.08M

Celyad Oncology S.A. (CYAD) Preço e Capitalização de Mercado

Celyad Oncology S.A. is a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing chimeric antigen receptor T (CAR-T) cell therapies specifically for oncology. Its most advanced therapeutic programs include several candidates undergoing clinical trials. CYAD-101 is an allogeneic CAR-T treatment currently in a Phase 1b study targeting metastatic colorectal cancer. Another allogeneic candidate, CYAD-211, utilizes short hairpin RNA (shRNA) technology and is being evaluated in a Phase 1 trial for patients with relapsed or refractory multiple myeloma. Furthermore, CYAD-02, an autologous CAR-T therapy, is progressing through a Phase 1 study to address relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. In its preclinical pipeline, the company is developing CYAD-203. This is a non-gene-edited allogeneic CAR-T candidate designed to co-express interleukin-18 (IL-18) cytokine with natural killer group 2D ligands (NKG2D), intended for the treatment of various solid tumors. Celyad Oncology holds a licensing agreement with Novartis International AG, granting rights to U.S. patents concerning allogeneic CAR-T cells. Additionally, it has established research and development collaborations and licensing agreements with Horizon Discovery Group plc, leveraging their shRNA technology to create an alternative non-gene-edited allogeneic platform. Established in 2004, the company was initially known as Celyad SA before rebranding to Celyad Oncology SA in June 2020. Its headquarters are situated in Mont-Saint-Guibert, Belgium.

Preço para CYAD	Ativo B	Capitalização de mercado de B	Resultados
$118,874 $15.08M	NVDA	$5.321T	+35,288,012.11%
$100,694 $15.08M	AAPL	$4.507T	+29,891,131.52%
$92,278.82 $15.08M	GOOG	$4.131T	+27,393,063.72%
$79,872.69 $15.08M	MSFT	$3.575T	+23,710,278.66%
$62,475.52 $15.08M	AMZN	$2.797T	+18,545,890.86%

Preço para CYAD

Ativo B

Capitalização de mercado de B

Resultados

$118,874 $15.08M